-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
The Practice and Safety of Injecting Insulin through Clothes among Patients with Diabetes in Bahrain
Husain T, Majeda M, Ebtihal Al Y and Basma Al S
Research Article: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation